RIVKAH COLEN to Young Adult
This is a "connection" page, showing publications RIVKAH COLEN has written about Young Adult.
Connection Strength
0.395
-
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers. J Immunother Cancer. 2021 04; 9(4).
Score: 0.053
-
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol. 2018 Aug; 139(1):125-133.
Score: 0.043
-
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607.
Score: 0.042
-
Silent Sentence Completion Shows Superiority Localizing Wernicke's Area and Activation Patterns of Distinct Language Paradigms Correlate with Genomics: Prospective Study. Sci Rep. 2017 09 21; 7(1):12054.
Score: 0.041
-
Diffusion Weighted Magnetic Resonance Imaging Radiophenotypes and Associated Molecular Pathways in Glioblastoma. Neurosurgery. 2016 08; 63 Suppl 1:127-135.
Score: 0.038
-
Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity. Sci Rep. 2016 05 06; 6:25295.
Score: 0.038
-
Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro Oncol. 2015 Nov; 17(11):1525-37.
Score: 0.036
-
Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project. BMC Med Genomics. 2014 Jun 02; 7:30.
Score: 0.033
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.012
-
Comparison of functional localization accuracy with different co-registration strategies in presurgical fMRI for brain tumor patients. Med Phys. 2018 Jul; 45(7):3223-3228.
Score: 0.011
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.010
-
Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma. Comput Methods Programs Biomed. 2017 Mar; 140:249-257.
Score: 0.010
-
Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors. J Clin Oncol. 2016 10 10; 34(29):3562-3569.
Score: 0.010
-
Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol. 2016 Feb; 118(2):315-22.
Score: 0.009
-
Change in postsurgical cavity size within the first 30 days correlates with extent of surrounding edema: consequences for postoperative radiosurgery. J Comput Assist Tomogr. 2014 May-Jun; 38(3):457-60.
Score: 0.008